Delivery Order SPE2DB20D1004-SPE2DB23FG5J7
- Not listed
- This federal contract award is for the delivery of Citalopram HBR 40 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,613.37, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of February 15, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,474.36 firm fixed-price delivery order is for the supply of Citalopram HBr 40 mg tablets. The contract has an ultimate completion date of November 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Citalopram HBR 40 mg tablets to the Defense Logistics Agency (DLA). The $7,958.72 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of January 26, 2024 and was awarded on January 25, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support...
- This federal contract award is for the delivery of Citalopram HBR 40 mg tablets in quantities of 500 per bottle. The contract, valued at $7,947.41, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Citalopram HBR 20 mg tablets to the Defense Logistics Agency (DLA). The $19,501.66 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award is for the delivery of 4,560,923,571 units of Citalopram HBR 40mg tablets to the Defense Logistics Agency (DLA) Medical Supply Chain. The contract, valued at $18,901.93, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 12, 2023, with a completion date of May 15, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of 4,564,010,669 units of Citalopram HBR 40 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,666.92, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a performance period through March 20, 2024. Amerisourcebergen Drug Corp has received numerous...
- This federal contract award, valued at $1,469.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,983,231 units of Citalopram HBR 40 mg tablets, a pharmaceutical product, with a completion date of May 19, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract was awarded through full and open competition, with no set-aside designation. Amerisourcebergen...
- This federal contract award is for the delivery of Citalopram HBR 40 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,244.13, and has an ultimate completion date of February 1, 2024. The contract was awarded on January 31, 2024, and there is no set-aside designation. Amerisourcebergen Drug...
- This federal contract award, valued at $6,241.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Citalopram HBR 40 MG Tablets in 500-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FG5J7Delivery Order
This federal contract award is for the delivery of citalopram HBR 40 mg tablets in quantities of 500 to the Defense Logistics Agency (DLA). The contract, valued at $1,201.28, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which runs through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/11/23 |